These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7254231)

  • 21. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.
    Tzartos SJ; Morel E; Efthimiadis A; Bustarret AF; D'Anglejan J; Drosos AA; Moutsopoulos HA
    Clin Exp Immunol; 1988 Oct; 74(1):80-6. PubMed ID: 2464451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsp60 and AChR cross-reactivity in myasthenia gravis: An update.
    Cappello F; Marino Gammazza A; Zummo L; Conway de Macario E; Macario AJ
    J Neurol Sci; 2010 May; 292(1-2):117-8. PubMed ID: 20236663
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding of myasthenia gravis antibodies to different acetylcholine receptor preparations.
    Zielinski A; Brenner T; Abramsky O
    Isr J Med Sci; 1982 Apr; 18(4):483-6. PubMed ID: 7085248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the acetylcholine receptor in myasthenic dogs.
    Garlepp M; Farrow B; Kay P; Dawkins RL
    Immunology; 1979 Aug; 37(4):807-10. PubMed ID: 500127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis.
    Polizzi A; Huson SM; Vincent A
    Teratology; 2000 Nov; 62(5):332-41. PubMed ID: 11029151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW; Pestronk A; Drachman DB; Rechthand E
    Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin.
    Olsberg CA; Mikiten TM; Krolick KA
    J Immunol; 1985 Nov; 135(5):3062-7. PubMed ID: 3876374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS
    Ann Neurol; 1981 Nov; 10(5):437-47. PubMed ID: 7305297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Xiao BG; Lu CZ; Höjeberg B; Link H
    J Neurol Sci; 1991 Sep; 105(1):118-23. PubMed ID: 1665503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia.
    Heidenreich F; Vincent A; Newsom-Davis J
    Autoimmunity; 1988; 2(1):31-7. PubMed ID: 3155153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.